Top Back to top

Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)

Acute Leukemia Working Party (ALWP)
Study type:
Study number:
8421103
Type of Stem Cell Treatment:
Allogeneic
Diseases:
Acute Myeloid Leukaemia (AML)
Acute Lymphatic Leukaemia (ALL)
Short title:
Prevalence and outcome of CNS relapse after alloHSCT in patients suffering from AML and ALL
Primary objective:
 
Key inclusion criteria:
 
Country:
 
Principal investigator:
Sabine BLUM , Yves Chalandon
EBMT Study coordinator:
Audrey MAILHOL
Study coordinator email:
audreymailhol@upmc.fr